Introducing clot removal treatment for acute ischemic stroke at a regional hospital
Studies a training-based quality program as a hospital starts treating strokes with clot removal.
Plain-language title generated from the registry record
Registry title: Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality
Key facts
- Where
- Kristiansand, NorwaySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT04942041, who can take part
Where in Norway
- Sørlandet Hospital Health TrustKristiansand, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sorlandet Hospital HF
- Trial code
- NCT04942041
- Record updated
- 29 December 2023
- Original description
The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.Read full original descriptionShow less
Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality.
The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.
Inclusion: Adult patients; Large vessel occlusion stroke.
Exclusion: Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area; More than 24 hours after stroke onset.